Taher A. Tweigeri-Al

Riyadh, 11211, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.

Eugenoplatin (a phyto-chemo drug conjugate) targets cancer stem cells through inhibition of the β-catenin signaling in triple-negative breast cancer cells.

Journal: Journal of translational medicine

Published: December 04, 2025

Subtype-Specific m6A circRNA Methylation Patterns Identify Epigenetic Biomarker Candidates of Potential Diagnostic and Prognostic Significance in Breast Cancer.

Subtype-Specific m6A circRNA Methylation Patterns Identify Epigenetic Biomarker Candidates of Potential Diagnostic and Prognostic Significance in Breast Cancer.

Journal: International journal of molecular sciences

Published: November 11, 2025

Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.

Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial.

Journal: Scientific reports

Published: October 30, 2025

Fascin Drives Breast Cancer Cell Proliferation Partly by Modulating the Cell Cycle Checkpoint Regulators of the G1-S Phase.

Fascin Drives Breast Cancer Cell Proliferation Partly by Modulating the Cell Cycle Checkpoint Regulators of the G1-S Phase.

Journal: Cells

Published: October 08, 2025

Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia.

Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia.

Journal: Oncology and therapy

Published: October 06, 2025

Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort.

Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort.

Journal: Breast cancer research : BCR

Published: September 15, 2025

Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.

Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.

Journal: International journal of molecular sciences

Published: July 17, 2025

A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.

A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort study.

Journal: Cell death discovery

Published: April 05, 2025

Molecular Subtypes of Breast Cancer in Arab Women: Distribution and Prognostic Insights.

Molecular Subtypes of Breast Cancer in Arab Women: Distribution and Prognostic Insights.

Journal: Journal of epidemiology and global health

Published: January 14, 2025

Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC).

Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC).

Journal: Cancers

Published: August 01, 2024

Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer.

Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer.

Journal: Oncology letters

Published: January 12, 2024

Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer.

Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancer.

Journal: Cell death discovery

Published: April 18, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026